Amylin/DAP Antikörper (N-Term)
Kurzübersicht für Amylin/DAP Antikörper (N-Term) (ABIN927970)
Target
Alle Amylin/DAP (IAPP) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- IAPP antibody was raised in rabbit using the N terminal of IAPP as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
IAPP Blocking Peptide, (ABIN5614120), is also available for use as a blocking control in assays to test for specificity of this IAPP antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Amylin/DAP (IAPP) (Islet Amyloid Polypeptide (IAPP))
-
Andere Bezeichnung
- IAPP
-
Hintergrund
- Islet, or insulinoma, amyloid polypeptide is commonly found in pancreatic islets of patients suffering diabetes mellitus type II, or harboring an insulinoma. While the assosciation of amylin with the development of type II diabetes has been known for some time, a direct causative role for amylin has been harder to establish. Studies suggest that amylin, like the related beta-amyloid (Abeta) associated with Alzheimer's disease, can induce apoptotic cell-death in particular cultured cells, an effect that may be relevant to the development of type II diabetes. Synonyms: Polyclonal IAPP antibody, Anti-IAPP antibody, islet amyloid polypeptide antibody, AMYLIN antibody, DAP antibody, IAP antibody.
-
Pathways
- Hormone Activity, Feeding Behaviour
Target
-